Could a common supplement tame lupus? new trial investigates
NCT ID NCT00775476
First seen May 01, 2026 · Last updated Jun 17, 2026 · Updated 7 times
Summary
This study tests whether the supplement N-acetylcysteine (NAC) can help control lupus, a chronic autoimmune disease. About 290 adults with lupus will first take NAC for 3 months to find a safe dose, then half will continue NAC and half will get a placebo for another 9 months. The goal is to see if NAC improves disease activity and reduces the need for steroids.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30307, United States
-
Hospital for Special Surgery
New York, New York, 10021, United States
-
Penn State MS Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
SUNY Upstate Medical University
Syracuse, New York, 13210, United States
-
St. Luke's University Health Network
Allentown, Pennsylvania, 18102, United States
-
The Ohio State University
Columbus, Ohio, 43210, United States
-
University of Columbia
New York, New York, 10032, United States
-
University of Kentucky
Lexington, Kentucky, 40536, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15261, United States
-
VA Medical Center
Oklahoma City, Oklahoma, 73104, United States
-
Yale Center for Clinical Investigation
New Haven, Connecticut, 06519, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.